ArticleInflammopharmacology2024

Empagliflozin repurposing in Parkinson's disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways.

Noha Nabil Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.